Carpenter D. Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA.; 2010. Publisher's Version i9205.pdf

Carpenter D, Keyhani S, Anderson G, Hebert P, Wang S. “U.S. Pharmaceutical Innovation in an International Context” . American Journal of Public Health. 2010;(6) :1075-1080. Publisher's Version

Carpenter D, Grimmer J, Lomazoff E. “Approval Regulation and Endogenous Consumer Confidence: Theory and an Analogies to Licensing, Safety and Financial Regulation”. Regulation and Governance . 2010;4 (4).

Carpenter D, Moffitt S, Moore C, Rynbrandt R, Ting M, Yohai I, Zucker EJ. Early-Entrant Protection in Approval Regulation: Theory and Evidence from FDA Drug Review. Journal of Law Economics and Organization . 2010;26 (2).

Carpenter D. “Institutional Strangulation: Bureaucratic Politics and Financial Reform in the Obama Administration”. Perspective on Politics. 2010;8 (3) :825-46.

Carpenter D. “Reputation Information and Confidence – The Political Economy of Pharmaceutical Regulation”. Public Choice and Public Law . 2010.